Variables | Group D (N = 50) | Group O (N = 50) | p |
---|---|---|---|
Male | 18 (36) | 27 (54) | 0.07 |
Female | 32 (64) | 23 (46) | |
Age (years) | 55.1 ± 12.1 | 57.1 ± 16 | 0.68 |
Height (cm) | 162.1 ± 7.3 | 163.4 ± 8.1 | 0.8 |
Weight (kg) | 61.3 ± 11.5 | 62.3 ± 10.4 | 0.34 |
BMI (kg/m2) | 23.2 ± 3.1 | 23.3 ± 3.1 | 0.77 |
ASA classification | |||
 I | 7 (14) | 4 (8) | 0.37 |
 II | 38 (76) | 37 (74) | |
 III | 5 (10) | 9 (18) | |
Pre-op lung condition | |||
 FEV1/FVC (% of prediction) | 83.8 ± 7.1 | 83.7 ± 8.1 | 0.92 |
Smoker | 3 (6) | 4 (8) | 0.7 |
Diagnosis | |||
 Adenocarcinoma | 29 (58) | 21 (42) | 0.43 |
 Metastatic lung cancer | 12 (24) | 15 (30) | |
 Benign lung tumor | 1 (2) | 2 (4) | |
 Others | 8 (16) | 12 (24) | |
Comorbidity | |||
 No systemic disease | 7 (14) | 10 (20) | 0.42 |
 Hepatitis carrier | 6 (12) | 7 (14) | 0.77 |
 Extrapulmonary tumor | 15 (30) | 22 (44) | 0.15 |
 Cardiac disease | 6 (12) | 5 (10) | 0.75 |
 Hypertension | 15 (30) | 13 (26) | 0.66 |
 Diabetes mellitus | 7 (14) | 5 (10) | 0.54 |
 Pulmonary disease (COPD, asthma) | 2 (4) | 3 (6) | 0.65 |